JP2020503280A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020503280A5 JP2020503280A5 JP2019530099A JP2019530099A JP2020503280A5 JP 2020503280 A5 JP2020503280 A5 JP 2020503280A5 JP 2019530099 A JP2019530099 A JP 2019530099A JP 2019530099 A JP2019530099 A JP 2019530099A JP 2020503280 A5 JP2020503280 A5 JP 2020503280A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- cancer
- aryl
- chain
- mitochondrial
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022200267A JP7689690B2 (ja) | 2016-12-29 | 2022-12-15 | ヒドロキシ安息香酸誘導体、その方法および使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PT109818 | 2016-12-29 | ||
| PT10981816 | 2016-12-29 | ||
| PCT/IB2017/058508 WO2018122789A1 (en) | 2016-12-29 | 2017-12-29 | Hydroxybenzoic acid derivatives, methods and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022200267A Division JP7689690B2 (ja) | 2016-12-29 | 2022-12-15 | ヒドロキシ安息香酸誘導体、その方法および使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020503280A JP2020503280A (ja) | 2020-01-30 |
| JP2020503280A5 true JP2020503280A5 (enExample) | 2021-03-04 |
Family
ID=61074472
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019530099A Pending JP2020503280A (ja) | 2016-12-29 | 2017-12-29 | ヒドロキシ安息香酸誘導体、その方法および使用 |
| JP2022200267A Active JP7689690B2 (ja) | 2016-12-29 | 2022-12-15 | ヒドロキシ安息香酸誘導体、その方法および使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022200267A Active JP7689690B2 (ja) | 2016-12-29 | 2022-12-15 | ヒドロキシ安息香酸誘導体、その方法および使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US11078222B2 (enExample) |
| EP (1) | EP3562830B1 (enExample) |
| JP (2) | JP2020503280A (enExample) |
| KR (1) | KR102750630B1 (enExample) |
| CN (1) | CN110114365B (enExample) |
| BR (1) | BR112019011303B1 (enExample) |
| CA (1) | CA3048966A1 (enExample) |
| WO (1) | WO2018122789A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021085906A1 (ko) * | 2019-10-30 | 2021-05-06 | 주식회사 퓨전바이오텍 | 미토콘드리아 표적 화합물 및 이를 포함하는 노화 관련 질환의 치료 또는 예방을 위한 조성물 |
| WO2023053059A1 (en) * | 2021-09-30 | 2023-04-06 | Universidade Do Porto | Antifouling compound, method and uses thereof |
| US20250312360A1 (en) * | 2022-05-13 | 2025-10-09 | Virginia Tech Intellectual Properties, Inc. | Mitochondrial antioxidant treatment for cask-linked neurodevelopmental disorders |
| KR20240040435A (ko) * | 2022-09-21 | 2024-03-28 | 울산과학기술원 | 미토콘드리아 표적 화합물을 유효성분으로 포함하는 망막 변성 치료용 약학적 조성물 |
| KR102894216B1 (ko) * | 2022-12-15 | 2025-12-18 | 울산과학기술원 | Trap-1 억제제 |
| CN116210697B (zh) * | 2023-03-02 | 2024-05-14 | 西北农林科技大学 | 反式肉桂酸在提高苹果树腐烂病抗性中的应用 |
| KR20250126454A (ko) * | 2024-02-16 | 2025-08-25 | 울산과학기술원 | 암 세포의 티오에스테라제 및 활성산소종에 의해 자가 조립 중합되는 단량체 및 이의 용도 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010126719A1 (en) * | 2009-04-27 | 2010-11-04 | Mcw Research Foundation, Inc. | Neuroprotective compounds and their use |
| GB201320636D0 (en) * | 2013-11-22 | 2014-01-08 | Medical Res Council | Compounds |
| CN109328062A (zh) * | 2016-03-08 | 2019-02-12 | 密执安大学评议会 | 小分子活性氧簇诱导剂和线粒体活性抑制剂 |
| CN109843896B (zh) * | 2016-10-14 | 2022-12-20 | 波尔图大学 | 羟基肉桂酸衍生物、方法及其用途 |
-
2017
- 2017-12-29 KR KR1020197016316A patent/KR102750630B1/ko active Active
- 2017-12-29 WO PCT/IB2017/058508 patent/WO2018122789A1/en not_active Ceased
- 2017-12-29 US US16/475,277 patent/US11078222B2/en active Active
- 2017-12-29 CN CN201780081193.XA patent/CN110114365B/zh active Active
- 2017-12-29 EP EP17835943.6A patent/EP3562830B1/en active Active
- 2017-12-29 JP JP2019530099A patent/JP2020503280A/ja active Pending
- 2017-12-29 BR BR112019011303-7A patent/BR112019011303B1/pt active IP Right Grant
- 2017-12-29 CA CA3048966A patent/CA3048966A1/en active Pending
-
2022
- 2022-12-15 JP JP2022200267A patent/JP7689690B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3833343B1 (en) | Heterocyclic flavone derivatives, compositions, and methods related thereto | |
| JP2023051961A5 (enExample) | ||
| EP3630101B1 (en) | Tegavivint for use in the treatment of pulmonary fibrosis | |
| TN2013000293A1 (en) | Derivatives of azaindazole or diazaindazole type as medicament | |
| JP7341034B2 (ja) | プロテオパチーの処置のためのベンジリデングアニジン誘導体の新規な治療的使用 | |
| MX2018001196A (es) | Compuesto derivado de amida de 1,3,4-oxadiazol como inhibidor de histona desacetilasa 6 y composición farmacéutica que lo contiene. | |
| NZ740429A (en) | 1,3,4-oxadiazole derivative compounds as histone deacetylase 6 inhibitor, and the pharmaceutical composition comprising the same | |
| MX2021006265A (es) | Derivados de panteteina y usos de los mismos. | |
| CA2851996A1 (en) | Pharmaceutical compositions for substituted quinazolinones | |
| KR20180058829A (ko) | Ezh2 억제제로 수모세포종을 치료하는 방법 | |
| SG11201806438UA (en) | Fused Pyrazole Derivatives, Preparation Method Thereof, And Use Thereof In Treatment Of Cancers, Inflammation And Immune Diseases | |
| CN110114365B (zh) | 羟基苯甲酸衍生物、方法及其用途 | |
| JP6243849B2 (ja) | 口腔用組成物及び口腔用活性酸素消去剤 | |
| EA201171087A1 (ru) | СПОСОБЫ ВВЕДЕНИЯ (4aR,10aR)-1-н-ПРОПИЛ-1,2,3,4,4a,5,10,10a-ОКТАГИДРОБЕНЗО[g]ХИНОЛИН-6,7-ДИОЛА И РОДСТВЕННЫХ СОЕДИНЕНИЙ ЧЕРЕЗ СЛИЗИСТУЮ ОБОЛОЧКУ ПОЛОСТИ РТА, СЛИЗИСТУЮ ОБОЛОЧКУ НОСА ИЛИ КОЖУ И ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ НА ИХ ОСНОВЕ | |
| AU2015204609B2 (en) | Novel functionalized 1,3-benzene diols and their method of use for the treatment of hepatic encephalopathy | |
| EP4226919A1 (en) | Ferroptosis inhibitor | |
| JP7405484B2 (ja) | うつ病及び片頭痛の治療に使用される新規化合物 | |
| BR112019010816A2 (pt) | composto de fórmula i, composto de fórmula ii, composto de fórmula iii, composto de fórmula iv, composto de fórmula v, composição farmacêutica, compostos, composto de fórmula viii, composto de fórmula ix, e composto de fórmula x | |
| JP7798358B2 (ja) | 癌の処置のためにタキサンと共にｆａｂｐ５阻害剤を使用する併用療法 | |
| CN112654355A (zh) | 用于骨骼肌调节的raf-1激酶抑制剂化合物、其方法和用途 | |
| JP2021105061A (ja) | アミロイド線維形成の抑制又は阻害剤 | |
| WO2021069736A1 (en) | New carbazole derivatives sensitizing cells to anti-cancer agents | |
| US12343316B2 (en) | Cannabidiol and/or derivatives thereof for use in the treatment of mitochondrial diseases | |
| US20220315544A1 (en) | Uses of doxadiazines compounds | |
| WO2017219086A1 (en) | Anti-ageing compounds |